🔥 42 IAS Prelims 2026 Questions Themes Came Directly from Our Expected Topics. Click for the Proof. 🔥 Admissions Open for 21st November GS Batch. Register Now. 🔥 Heartiest Congratulations to all UPSC CSE Mains 2026 qualifiers! 31+ students from RICE IAS have successfully cleared the Mains examination.

GLP-1 Drugs (Glucagon-Like Peptide-1 Receptor Agonists)

What are GLP-1 Drugs?

  • GLP-1 drugs are medications known as GLP-1 receptor agonists, used primarily for managing Type 2 diabetes and obesity.
  • They mimic the action of the naturally occurring GLP-1 hormone, which is released by the intestine after food intake.
  • They regulate blood glucose levels, suppress appetite and promote weight loss.

How Do GLP-1 Drugs Work?

  • Stimulate insulin secretion: Promote insulin release from the pancreas in response to elevated blood glucose.
  • Suppress glucagon: Reduce glucagon secretion, limiting excess glucose release by the liver.
  • Slow gastric emptying: Delay the movement of food from the stomach into the intestine, increasing the feeling of fullness.
  • Reduce appetite: Act on appetite-regulating pathways, helping reduce food intake and body weight.

Major GLP-1 Medications

DrugImportant feature
SemaglutideAvailable as injection and oral tablets
LiraglutideGLP-1 receptor agonist
DulaglutideLong-acting GLP-1 receptor agonist
ExenatideGLP-1 receptor agonist
Exenatide Extended ReleaseLong-acting formulation
TirzepatideDual GIP and GLP-1 receptor agonist

Regulation of GLP-1 Drugs in India

  • Regulatory Authority: Central Drugs Standard Control Organisation (CDSCO), headed by the Drug Controller General of India (DCGI).
  • Prescription Requirement: GLP-1 medicines are prescription-based drugs and should be used under qualified medical supervision.
  • March 10, 2026 Advisory: DCGI issued an advisory to manufacturers against misleading advertisements and promotion encouraging non-prescription use.
  • Regulatory Inspections: 49 businesses, including online pharmacy warehouses, wholesalers, retailers and weight-loss clinics, were inspected.
  • Penalties: Violations may attract licence cancellation, fines and legal action under applicable laws.

Conclusion

GLP-1 drugs represent an important advancement in managing Type 2 diabetes and obesity. However, their growing popularity necessitates prescription-based access, patient awareness and effective pharmaceutical regulation to ensure safe and rational use.

This Concept has been discussed in the following article:

Retatrutide: A Novel Drug for Obesity and Osteoarthritis